atau cari berdasarkan hari
Bio Farma prepares up to 18 million doses of Covid-19 vaccine for May 2021 which comes from the 59.5 million Sinovac bulk doses.
Health Minister Budi Gunadi confirmed that the Covid-19 vaccine stock for April and May is sufficient amid concerns that it might be disrupted.
Sinopharm Covid-19 vaccine will be allocated to the 'gotong-royong' vaccine program under the coordination of Kadin.
The Asian Development Bank (ADB) has approved a $450 million loan to Indonesia to help Bio Farma deliver safe and effective vaccines against COVID-19.
Bio Farma will start operating its new production facility in April to boost the manufacturing of COVID-19 vaccines.
Bio Farma has said that Indonesia has been listed among the 10 countries in the world that are leading in vaccinating their people against COVID-19.
Bio Farma President Director Honesti Basyir said that Indonesia is one of the leading countries in total Covid-19 vaccine doses administered.
Indonesia has just received its sixth import of Sinovac Covid-19 vaccine bulks or in the form of raw materials on Thursday, March 25.
The government explained that the Covid-19 vaccines currently in use are Sinovac vaccine seeds further developed by Bio Farma.
Eijkman Institute reported the development of the home-grown Merah Putih vaccine.
In a House hearing with DPR's Health Commission, the BPOM gave updates on the Covid-19 vaccines processed by Bio Farma.
State-owned pharmaceutical holding firm PT Bio Farma is preparing a non-subsidized COVID-19 vaccination program under mutual cooperation.
Researcher from Unpad, Kusnandi Rusmil, sheds light on the expiration date of the Covid-19 vaccine by Sinovac that is reportedly in March 2021.
Bio Farma president recalled the challenges the state-pharmaceutical firm had to endure in order to obtain Sinovac Covid-19 vaccines.
Bio Farma said that 500,000 doses of Sinopharm vaccines will arrive in Indonesia at the end of March.
The government is preparing a private Covid-19 vaccination scheme or non-subsidized one to speed up its vaccination program.
Four brands of the COVID-19 vaccine will reportedly be used in the non-subsidized vaccination program.
Bio Farma is currently seeking to partner with Sinopharm and Moderna for Indonesia's private vaccination program.
Bio Farma said there woul be 11.4 million doses ready for use in March 2021 after COVID-19 vaccination phase one for healthcare workers was completed.
Bio Farma is eyeing to produce until 250 million doses of Covid-19 vaccine in a year.